Progyny, Inc. Common Stock
PGNYProgyny, Inc. (PGNY) is a healthcare company that specializes in fertility benefits management. It provides comprehensive fertility solutions and coverage options for employers and health plans, aiming to improve access to fertility treatments and support individuals and couples on their reproductive journey.
Company News
Progyny's CEO Peter Anevski purchased 79,500 shares worth approximately $1.9 million, increasing his direct ownership to 680,251 shares. The purchase signals confidence in the company's performance, which has seen 9% sales growth and near-100% customer retention.
Progyny reported strong Q3 earnings with 9% sales growth and 23% adjusted growth, maintaining high client retention and demonstrating resilience after losing Amazon as a customer.
Progyny, Inc. (PGNY) will report its Q1 2025 financial results on May 8, 2025, and host a conference call to discuss the results.
Progyny, a leading fertility benefits provider, reported strong Q4 2024 results, with revenue and adjusted EPS exceeding analyst estimates. However, the company faced setbacks, including the loss of a significant client, which affected its growth projection for 2025. Variability in member engagement remains a concern, and the company's future rev...
Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of Progyny, Inc. (PGNY). Shareholders may be entitled to damages and corporate governance reforms.
